Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast and Beclomethasone in Chronic Asthma
NCT00911547Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 1995
- Primary completion
- Apr 1996
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of montelukast in asthma (4 arms), sponsored by Organon & Co. Primary endpoints: Forced Expiratory Volume in 1 Second at 16 weeks and Daytime Asthma Symptoms at 16 weeks. Started Mar 1995; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00911547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911547.